Pancreatic Cancer Research

ResearcherYan'an UniversityActive in the last 2 years

Xiaobin Liu

Matched on ORCID iD 0009-0000-5630-2700; OpenAlex author ID A5100765474.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Saikosaponin D overcomes gemcitabine resistance in pancreatic cancer via AKT/mTOR pathway inhibition and synergistic induction of apoptosis and autophagy. Co-author DOI 10.3892/or.2025.9033↗
  2. [Saikosaponin D regulates apoptosis and autophagy of pancreatic cancer Panc-1 cells via Akt/mTOR pathway]. Last author DOI 10.19540/j.cnki.cjcmm.20230713.401↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Rui Zheng · 2 shared papers, 2023–2026
  2. Yusi Liu · 2 shared papers, 2023–2026
  3. Yufu Zhang · 1 shared paper, 2026
  4. Yuehong Guan · 1 shared paper, 2023

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.